Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre, Randomised, Open Label, Non-inferiority Trial to Evaluate the Efficacy and Safety of Deferiprone Compared to Deferasirox in Patients Aged From 1 Month to Less Than 18 Years Affected by Transfusion Dependent Haemoglobinopathies

NCT01825512 is registered in ClinicalTrials.gov with Consorzio per Valutazioni Biologiche e Farmacologiche as lead sponsor.

NCT NCT01825512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01825512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre, Randomised, Open Label, Non-inferiority Trial to Evaluate the Efficacy and Safety of Deferiprone Compared to Deferasirox in Patients Aged From 1 Month to Less Than 18 Years Affected by Transfusion Dependent Haemoglobinopathies
Lead sponsor
Consorzio per Valutazioni Biologiche e Farmacologiche
Phase
Phase 3
Overall status
Completed
Start date
March 17, 2014
Completion date
September 21, 2017
Enrollment
435 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

chronic iron overload